A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration

NCT00447954 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage

Interventions

COMBINATION_PRODUCT: High Dose NT-501 implant
COMBINATION_PRODUCT: Low Dose NT-501 implant
OTHER: Sham

Sponsor

Neurotech Pharmaceuticals